Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole as early adjuvant treatment in postmenopausal patients with primary breast cancer
2004-003889-15Phase 3Completed
- Sponsor
- Novartis
- Start
- Jun 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of letrozole in breast cancer, sponsored by Novartis. Primary endpoint: Disease-free survival. Started Jun 2006; status: completed.
02
Drugs
letrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2004-003889-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-003889-15.